[HTML][HTML] Systematic review with network meta-analysis: antidiabetic medication and risk of hepatocellular carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng, TT Zou… - Scientific reports, 2016 - nature.com
Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We
aimed to compare the use of different antidiabetic strategies and the incidence of HCC …

[PDF][PDF] Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng, TT Zou… - cyberleninka.org
Results Study characteristics. The participant flow diagram for study inclusion in the meta-
analysis is shown in Fig. 1. A total of thirteen studies were retrieved, which were all …

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng, TT Zou… - Scientific Reports, 2016 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Antidiabetic medication may modify the
incidence of hepatocellular carcinoma (HCC). We aimed to compare the use of different …

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng… - Scientific …, 2016 - pubmed.ncbi.nlm.nih.gov
Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We
aimed to compare the use of different antidiabetic strategies and the incidence of HCC …

[HTML][HTML] Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng… - Scientific …, 2016 - ncbi.nlm.nih.gov
Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We
aimed to compare the use of different antidiabetic strategies and the incidence of HCC …

Systematic review with network meta-analysis: antidiabetic medication and risk of hepatocellular carcinoma.

ZYY Zhou YaoYao, ZGQ Zhu GuiQi, LT Liu Tian… - 2016 - cabidigitallibrary.org
Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We
aimed to compare the use of different antidiabetic strategies and the incidence of HCC …

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng… - Scientific …, 2016 - ui.adsabs.harvard.edu
Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We
aimed to compare the use of different antidiabetic strategies and the incidence of HCC …

[PDF][PDF] Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng, TT Zou… - researchgate.net
Results Study characteristics. The participant flow diagram for study inclusion in the meta-
analysis is shown in Fig. 1. A total of thirteen studies were retrieved, which were all …

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma.

YY Zhou, GQ Zhu, T Liu, JN Zheng, Z Cheng… - Scientific …, 2016 - europepmc.org
Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We
aimed to compare the use of different antidiabetic strategies and the incidence of HCC …